Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion Nicholas Jacobus Key Takeaways A $506 million Athlone expansion will increase oral tableting capacity and support current and pipeline GLP-1 medicines, improving supply availability outside the United States
On the reverse side, researchers found GLP-1 use was associated with an increased risk of gastrointestinal problems, including nausea, vomiting, diarrhea, and, in rare cases, paralysis of the stomach
For many Austin patients, the success of GLP-1 medications (like Ozempic or Wegovy) comes with an unexpected aesthetic "tax." While the scale is moving in the right direction, many are noticing a sudden increase in hair shedding and a loss of muscle definitionoften referred to as "GLP-1 Shedding" or muscle wasting
Several of the transformants should be grown in mini-culture preparations to check for expression of the target protein
Get In Touch Have questions about GHK-Cu products or research-use details
